As the accuracy of traditional cancer screening is called into question, molecular and genetic tests promise an alternative, noninvasive form of early detection.
In his latest book, clinical geneticist and biotech entrepreneur Dr. Phil Reilly chronicles centuries of medical progress that have contributed to recent breakthroughs in rare disease medicines, diagnostics, and clinical care. He says we're just...
New studies demonstrate that treating cancer based on its molecular vulnerabilities, rather than where it originated, could translate to better outcomes for patients
With a new genome sequence, more diverse data sets, and population-specific projects, scientists are making progress in representing humanity’s real DNA diversity.
Millions of people with weakened immune systems are poorly protected against Covid by current vaccines. Scientists in Germany have developed a new vaccine intended especially for them.
CAR T therapies juice the immune system. In cancer, they have cured patients who had little hope for survival. Now scientists are asking "What else can they do?"
It’s time to overhaul the chemical industry — for the sake of fenceline communities and the rest of the planet.
Scientists in Ontario used machine learning techniques to find telltale signs of cancer in blood samples that were collected up to seven years prior to conventional diagnosis.